ClinConnect ClinConnect Logo
Search / Trial NCT01807351

Progression From Impaired Fasting Glucose to Type 2 Diabetes Mellitus Among Subjects With and Without Hypertension in Primary Care Setting

Launched by KOWLOON HOSPITAL, HONG KONG · Mar 7, 2013

Trial Information

Current as of August 22, 2025

Completed

Keywords

Diabetes Mellitus Hypertension Impaired Fasting Glucose Primary Health Care Chinese

ClinConnect Summary

We aim at find out the progression of impaired fasting glucose (IFG) to type 2 Diabetes Mellitus (T2DM) among patients in general practice setting. We can understand the progress of the target patients so as to improve patient education, improve patient motivation in lifestyle modification.We are going to find out the annual incidence of Type 2 DM developement among the patients with and without hypertension Hypertensive patients with impaired fasting glucose are more likely to develop type 2 diabetes mellitus compare with normal tensive patients

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:We include all subjects age ≥18 attended the study centers with laboratory diagnosis of IFG by blood sugar 6.1 mmol/l to 6.9 mmol/l checked from 2002 to 2007 in the 6 study centres.
  • -
  • Exclusion Criteria:We excluded the subjects who have diagnosis of T2DM the years prior to the year of blood taken. We define T2DM by physician coding ICPC-2 of T90 Diabetes non-insulin dependent or prescription of antidiabetic drugs (British National Formulary(23) (BNF) section 6.1 and 6.2). We exclude the patients who had been admitted to Hong Kong Hospital Authority (HKHA)or attended HKHA specialty Clinic, or attended any GOPC with dispensing history of drug used in diabetes in BNF Section 6.1.1 insulins or 6.1.2 anti-diabetic drugs, or with ICPC coded with T90) during 1 Jan 2005 - 31 Dec 2006 (i.e. 2 year prior to starting of study period). We also excluded patient with the date of diagnosis of DM by above criteria earlier than the date of laboratory test results of IFG.
  • -

About Kowloon Hospital, Hong Kong

Kowloon Hospital, located in Hong Kong, is a leading healthcare institution dedicated to providing high-quality medical services and advancing clinical research. As a prominent clinical trial sponsor, Kowloon Hospital focuses on innovative therapeutic approaches and patient-centered care, aiming to enhance treatment outcomes across various medical fields. The hospital's commitment to ethical research practices and collaboration with multidisciplinary teams ensures robust clinical trial methodologies and the integration of the latest scientific advancements. Through its comprehensive research programs, Kowloon Hospital strives to contribute to the global medical community and improve patient health outcomes in Hong Kong and beyond.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials